Support independent, student-run journalism.

Your support helps give staff members from all backgrounds the opportunity to conduct meaningful reporting on important issues at Stanford. All contributions are tax-deductible.

Stanford researchers criticize Theranos-like biomedical ‘unicorns’ for lack of published research

Today, a new generation of innovative biomedical startups continue to win billion-dollar valuations and massive infusions of venture capital as they promise to revolutionize medicine and disrupt massive healthcare markets. According to a new January paper authored by three Stanford researchers, many of these companies also publish little to no peer-reviewed research.

Stanford researchers develop new, ‘three-dimensional’ CRISPR technology

On Thursday, a team led by assistant professor of bioengineering Stanley Qi released a study on a new form of gene-editing technology known as Clustered Regularly Interspaced Short Palindromic Repeats genome organization, or CRISPR-GO, which allows scientists to move pieces of DNA within a cell nucleus. In contrast, previous CRISPR technology has been used to “cut” and “paste” sections of the genetic code within individual pieces of DNA.

Nusse Lab studies complexity of Wnt signal protein as 2019 conference approaches

As the 2019 Gordon Research Conference — “Wnt Signaling Networks in Development, Disease and Regeneration” — approaches, Stanford developmental biology professor Roeland Nusse is continuing more than 30 years of work with the protein known as Wnt. He leads the Nusse Lab at Stanford in researching the effects and mechanisms of Wnt signaling, which has profound consequences on stem cell fate, tissue regeneration and cancer.